Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London
Pharming Group announced its participation in the 2026 Jefferies Global Healthcare Conference on November 16-19, with management presenting on November 18. The company reported strong revenue growth in Q3 2026 and highlighted the MHRA approval of Joenja® (leniolisib) as the first treatment specifically for children with APDS in the U.K., along with upcoming CVID topline data expected in November.